Clinical Experience with TTP-HUS: 24-Year Study of 178 Patients
Author Information
Author(s): Levandovsky Mark, Harvey Danielle, Lara Primo, Wun Ted
Primary Institution: Weill School of Medicine, Cornell University
Hypothesis
Can clinical or laboratory characteristics predict important short- and long-term outcomes in patients with TTP-HUS?
Conclusion
Plasma exchange therapy produced high response and survival rates in patients with TTP-HUS, with renal insufficiency associated with a decreased risk of relapse.
Supporting Evidence
- 30-day mortality was 16%, with 27 patients dying within this period.
- Plasma exchange was the principal treatment for 171 patients, with a mean of 8 exchanges.
- The overall 5-year survival rate was estimated at 55%.
Takeaway
This study looked at 178 patients with a serious blood condition and found that a specific treatment helped many of them survive and recover.
Methodology
Retrospective cohort study analyzing clinical and laboratory characteristics of patients treated with plasma exchange.
Potential Biases
Recall bias may affect follow-up data due to reliance on patient and physician interviews.
Limitations
The study is retrospective, which may introduce biases, and it spans 24 years, potentially affecting treatment consistency.
Participant Demographics
Predominantly female (68%), median age 49 years, with a diverse ethnic background reflective of California's population.
Statistical Information
P-Value
0.04
Confidence Interval
95% CI: 1.003–1.16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website